New insights into p53 regulation and gene therapy for cancer. (Q34047246)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11007953%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

review article

1 reference

title

New insights into p53 regulation and gene therapy for cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11007953%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

0 references

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11007953%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Martin Hermann

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11007953%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

author name string

A G Zeimet

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11007953%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

K Riha

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11007953%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

J Berger

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11007953%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

G Daxenbichler

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11007953%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

C Marth

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11007953%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

language of work or name

English

0 references

publication date

1 October 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11007953%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

published in

Biochemical Pharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11007953%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

volume

60

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11007953%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11007953%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

page(s)

1153-1163

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11007953%20AND%20SRC:MED&resulttype=core&format=json

T antigen is bound to a host protein in SY40-transformed cells

31 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

Characterization of a 54K Dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

Cellular immortalization by a cDNA clone encoding the transformation-associated phosphoprotein p53

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

Participation of p53 cellular tumour antigen in transformation of normal embryonic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

Regulation of the Cellular p53 Tumor Antigen in Teratocarcinoma Cells and Their Differentiated Progeny

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

Twenty years of p53 research: structural and functional aspects of the p53 protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

Cancer. p53, guardian of the genome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

Growth inhibition of human cervical cancer cells with the recombinant adenovirus p53 in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

Intraperitoneal gene therapy with adenoviral-mediated p53 tumor suppressor gene for ovarian cancer model in nude mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

Optimizing suicide gene therapy for head and neck cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

Cell adhesion and regulatory molecules involved in tumor formation, hemostasis, and wound healing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

Sequence-specific transcriptional activation is essential for growth suppression by p53.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

Definition of a consensus binding site for p53

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

Identification and classification of p53-regulated genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

Presence of a potent transcription activating sequence in the p53 protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

Interhelical angles in the solution structure of the oligomerization domain of p53: correction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

The XPB and XPD DNA helicases are components of the p53-mediated apoptosis pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

Association of human papillomavirus types 16 and 18 E6 proteins with p53.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

Inhibition of p53 transactivation required for transformation by adenovirus early 1B protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

Mdm2 promotes the rapid degradation of p53

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

The p53-mdm-2 autoregulatory feedback loop

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

Conformational and molecular basis for induction of apoptosis by a p53 C-terminal peptide in human cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

Two domains of p53 interact with the TATA-binding protein, and the adenovirus 13S E1A protein disrupts the association, relieving p53-mediated transcriptional repression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

p53, the cellular gatekeeper for growth and division

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

Human topoisomerase IIalpha and IIbeta interact with the C-terminal region of p53

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

A translation repressor element resides in the 3' untranslated region of human p53 mRNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

Negative feedback regulation of wild-type p53 biosynthesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

Regulation of p53 stability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

Expression of human p53 requires synergistic activation of transcription from the p53 promoter by AP-1, NF-kappaB and Myc/Max

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

WAF1, a potential mediator of p53 tumor suppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

Mice Lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

Tumor surveillance via the ARF-p53 pathway.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

E2F-1 accumulation bypasses a G1 arrest resulting from the inhibition of G1 cyclin-dependent kinase activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

Bcl-2 and the ICE family of apoptotic regulators: making a connection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

bax-deficiency promotes drug resistance and oncogenic transformation by attenuating p53-dependent apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

A novel cofactor for p300 that regulates the p53 response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

Apoptotic and growth-promoting activity of E2F modulated by MDM2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

E2F-1:DP-1 induces p53 and overrides survival factors to trigger apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

Induction of the growth inhibitor IGF-binding protein 3 by p53

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

The Fas pathway in apoptosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

Induction of the TRAIL receptor KILLER/DR5 in p53-dependent apoptosis but not growth arrest

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

Cell surface trafficking of Fas: a rapid mechanism of p53-mediated apoptosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

A model for p53-induced apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

Redox signalling and transition metals in the control of the p53 pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

An information-intensive approach to the molecular pharmacology of cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

p53-dependent apoptosis modulates the cytotoxicity of anticancer agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

p53 status and the efficacy of cancer therapy in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

Overexpression of p53 protein does not predict local-regional control or survival in patients with early-stage squamous cell carcinoma of the glottic larynx treated with radiotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

The prognostic significance of p53 expression for survival and local control in rectal carcinoma treated with surgery and postoperative radiotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

p53 and treatment of bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

p53-Dependent and -independent responses to cisplatin in mouse testicular teratocarcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

Effect of p53 status on sensitivity to platinum complexes in a human ovarian cancer cell line.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

A p53 and apoptotic independent role for p21waf1 in tumour response to radiation therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

Genetic mechanisms of tumor suppression by the human p53 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

A mutant p53 transgene accelerates tumour development in heterozygous but not nullizygous p53-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

p53 accumulation in ovarian carcinomas and its prognostic implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

Development and characterization of recombinant adenoviruses encoding human p53 for gene therapy of cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

Adenovirus-mediated p53 gene therapy has greater efficacy when combined with chemotherapy against human head and neck, ovarian, prostate, and breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

p21(WAF1/CIP1) inhibits initiator caspase cleavage by TRAIL death receptor DR4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

IFN-gamma induction of p21(WAF1) is required for cell cycle inhibition and suppression of apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

Chemosensitivity and p53-dependent apoptosis in epithelial ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

Clinical significance of serum and ascitic p53 autoantibodies in epithelial ovarian carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

Heparan sulfate glycosaminoglycans are involved in adenovirus type 5 and 2-host cell interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

The use of laser scanning cytometry to assess depth of penetration of adenovirus p53 gene therapy in human xenograft biopsies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

Pharmacological rescue of mutant p53 conformation and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

Adenovirus-mediated wild-type-p53-gene expression sensitizes TNF-resistant tumor cells to TNF-induced cytotoxicity by altering the cellular redox state

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

Oligomerization of oncoprotein p53.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

7 January 2021

Monoclonal antibody analysis of p53 expression in normal and transformed cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

7 January 2021

Adenovirus-mediated p53 growth inhibition of ovarian cancer cells is independent of endogenous p53 status

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

7 January 2021

Human adenovirus serotypes 3 and 5 bind to two different cellular receptors via the fiber head domain

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900442-1

7 January 2021

10.1016/S0006-2952(00)00442-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11007953%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference